Representative before the EPO

Employment test 11 - 50 employees
Company dna gill jennings and every llp
operating since 1912
Headquarter in London and 3 offices
active in Legal Services and IP Portfolio Processing

We have observed 4 EP applications Robert Edward Perry has served for within the last five+ years. (We consider all applications which have an EP A1 publication dated after December 17, 2012). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP11183830

The therapeutic use of tetrathiomolybdate

IPC classification:
A61K 33/24, A61P 9/10
Agent:
Robert Edward Perry, Gill Jennings & Every LLP
Status:
APPLICATION REFUSED
EP12188047

Use of amisulpride for treating chemotherapy-induced nausea and vomiting

IPC classification:
A61K 9/00, A61K 31/282, A61K 31/40, A61K 31/4178, A61K 31/485, A61K 47/12, A61P 1/08
Agent:
Multiple attorneys, Gill Jennings & Every LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12189630

Tetrathiomolybdate for use in the treatment of ischemia-reperfusion injury of the heart

IPC classification:
A61K 33/24, A61P 9/00, A61P 9/10, A61P 41/00, A61P 43/00
Applicant:
University College London
Agent:
Multiple attorneys, Gill Jennings & Every LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11716626

TETRATHIOMOLYBDATE FOR USE IN THE TREATMENT OF ISCHEMIA-REPERFUSION INJURY OF THE HEAD OR BRAIN

IPC classification:
A61K 33/24, A61P 7/04, A61P 9/00, A61P 9/10, A61P 41/00, A61P 43/00
Applicant:
University College London
Agent:
Multiple attorneys, Gill Jennings & Every LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT

Please Sign in to use this feature